NovellMJ, MorrealeCA. The relationship between inpatient fluoroquinolone use and Clostridium difficile–associated diarrhea. Ann Pharmacother2010; 44:826–31. DOI 10.1345/aph.1M696
2.
PépinJ, SahebN, CoulombeMA. Emergence of fluoroquinolones as the predominant risk factor for Clostridium difficile–associated diarrhea: a cohort study during an epidemic in Quebec. Clin Infect Dis2005; 41:1254–60. DOI 10.1086/496986
3.
DubberkeER, ReskeKA, YanY, OlsenMA, McDonaldLC, FraserVJ. Clostridium difficile–associated disease in a setting of endemicity: identification of novel risk factors. Clin Infect Dis2007; 45:1543–9. DOI 10.1086/523582
4.
BaxterR, RayGT, FiremanBH. Case-control study of antibiotic use and subsequent Clostridium difficile–associated diarrhea in hospitalized patients. Infect Control Hosp Epidemiol2008; 29(1):44–50. DOI 10.1086/524320
GaynesR, RimlandD, KillumE. Outbreak of Clostridium difficile infection in a long-term care facility: association with gatifloxacin use. Clin Infect Dis2004; 38:640–5. DOI 10.1086/381551
7.
McCuskerME, HarrisAD, PerencevichE, RoghmannMC. Fluoroquinolone use and Clostridium difficile–associated diarrhea. Emerg Infect Dis2003; 9:730–3.
8.
MutoCA, PokrywkaM, ShuttK. A large outbreak of Clostridium difficile–associated disease with an unexpected proportion of deaths and colectomies at a teaching hospital following increased fluoroquinolone use. Infect Control Hosp Epidemiol2005; 26:273–80. DOI 10.1086/502539
9.
YipC, LoebM, SalamaS, MossL, OldeJ. Quinolone use as a risk factor for nosocomial Clostridium difficile–associated diarrhea. Infect Control Hosp Epidemiol2001; 22:572–5. DOI 10.1086/501954
10.
DhallaIA, MamdaniMM, SimorAE, KoppA, RochonPA, JuurlinkDN. Are broad-spectrum fluoroquinolones more likely to cause Clostridium difficile–associated disease?Antimicrob Agents Chemother2006; 50:3216–9. DOI 10.1128/aac.00592-06
11.
WoodwardM. Epidemiology: study design and data analysis. 2nd ed.New York: Chapman & Hall/CRC, 2005.
12.
KellyCP, LaMontJT. Clostridium difficile—more difficult than ever. N Engl J Med2008; 359:1932–40. DOI 10.1056/NEJMra0707500
13.
RupnikM, WilcoxMH, GerdingDN. Clostridium difficile infection: new developments in epidemiology and pathogenesis. Nat Rev Microbiol2009; 7:526–36. DOI 10.1038/nrmicro2164
